This book highlights Charnoly body (CB) prevention/inhibition, charnolophagy induction, and charnolosome stabilization, as targets for safe and effective treatment of chronic intractable diseases (CIDs). Emerging glycomics, genomics, and epigenomics are described to further elucidate diversified charnolopathies.